BlossomHill Therapeutics, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 7 purchases
- GORDON CARL LBoard member · Aug 10, 2026Bought 625,000 sharesabout $10.0 million ·
- ORBIMED ADVISORS LLCBoard member · Aug 10, 2026Bought 625,000 sharesabout $10.0 million ·
- Schmid John P.Board member · Aug 10, 2026Bought 6,000 sharesabout $96 thousand ·
- Chen BihuaBoard member · Aug 10, 2026Bought 312,500 sharesabout $5.0 million ·
- Keyes Jason AChief Financial Officer · Aug 10, 2026Bought 700 sharesabout $11 thousand ·
- Liptak Vincent PaulGeneral Counsel · Aug 10, 2026Bought 2,200 sharesabout $35 thousand ·
- Liptak Vincent PaulGeneral Counsel · Aug 7, 2026Bought 2,500 sharesabout $40 thousand ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.